Hello, does anyone have information regarding ineffective rocuronium at their site?
Thank you

Now that the Waiver Elimination (MAT Act) eliminated the need for providers to obtain an X waiver to prescribe buprenorphine for opioid use disorder, my understanding is that buprenorphine should be like any other drug.

Does this mean that the 3-day rule for patients that present to a hospital for opioid withdrawal now applies only to methadone, but not to buprenorphine?

Have other organizations relaxed the rules for buprenorphine use, or do you have a different interpretation on how this legal change affects hospitals?

Good Morning,

Our health system currently uses the standard concentration for adult infusions recommended by the ASHP Standardize 4 Safety initiative of rocuronium 10 mg/mL (i.e., undiluted product). We have a physician that is questioning this concentration based on his interpretation of the package insert that states the diluted concentrations should be 0.5 mg/mL, 1 mg/mL, or 5 mg/mL. I am reaching out to see what other health systems are using as their standard concentration for adult infusions of rocuronium.

Thanks in advance!

Hi,

Has anyone been successful with anesthesiology barcode scanning medications prior to administration in the OR without use of a third party vendor (e.g. codonics)? We utilize Epic and Omnicell.
Thanks -
Maria Cumpston
West Virginia University Hospitals

Hello,

We're starting to see a few errors creep up relating to re-timing of medications. Currently nursing is responsible for retiming medications at our organization. In my previous organization, Pharmacy was responsible for retiming (and timing the first doses) of medications. We're considering whether we want to take on changing this workflow such that Pharmacy owns retiming.

Has anyone done this project to convert from nursing to pharmacy with who owns retiming med orders in your institution?

I welcome any comments, or recommendations.

Thanks!

Hello,
We're in the early stages of developing a multi-disciplinary structure for a Diversion Prevention Task Force.
Would anyone be willing to share their insights on development and/or any policies, workflows or SOPS related to this huge endeavor?

Thanks!

DiAnthia Patrick, PharmD
Childrens National Hospital
Washington, DC 20010
Director, Med Safety & Regulatory Compliance
dpatrick@childrensnational.org
(202) 476- 4798

Hi team, would love to get insight on how your institution is managing the Celestone shortage. We only have a few in stock and are trying to put together a plan.

Would appreciate your input!

Thanks
Abhi

Hi,
We are trying to review our medication history collection process to make it as robust as possible. The question I have for the group is, do you have the medication history collector (RN, pharmacy tech, other) document what the patient is actually taking on admission or what they are supposed to be taking?

Here are a few scenarios we are thinking through when we teach staff the best process and are struggling to provide clear guidance on what to document as active home med for instances like these.

Does anyone have policies around who can print patient arm bands?

Thank you,
Stacie Ethington MSN, RN
Nebraska Medicine